Mixed end of the month for the global markets - Monday Review, August 31

By: Miguel A. Rodriguez

09:45, 14 September 2020

The Chinese economy shows signs of recovery

The US

The fact that the Food and Drug Administration (FDA) is fast-tracking three potential #COVID-19 vaccines didn't affect the markets. USA30 lost 0.78%, and USA500 fell 0.22%. TECH100 added 0.68%. 

Gold went down 0.05% to $1,974 per ounce. 

Oil fell 0.40% to $42.80 per barrel, while Brent Oil slipped 0.11% to $45.55. 

The Dollar Index traded 0.22% lower at 91.99, marking the lowest level in more than two years.

Asia and Australia

The benchmarks traded higher, driven by the positive information received from Markit (an independent financial information provider) was seen by investors as signs of an #economic #recovery. HongKong45 rose 1.39%.

Japan225 added 1.89% as the race of appointing a new prime minister has started. 

Down under, Australia200 traded 0.11% higher, as the number of new COVID-19 infections reached a two-month low. 

USD/JPY traded at 106.10.

AUD/USD gained 0.33% and traded at 0.74.


The markets reacted in a mixed manner as Brexit talks reached a deadlock. Even though both the European Union and the UK are looking for a deal, that seems to be wishful thinking, as the British prime minister opposes most of the European demands. Europe50 closed down 0.6%. Germany30 fell 0.67%.

UK100 added 1.1%. 

EUR/USD rose 0.35% to 1.1945.

EUR/GBP gained 0.21% to 0.8929.

Read all about what happened in August on the financial markets here!

Sources: marketwatch.com, investing.com, express.co.uk

Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.